Cargando…
MYCN protein stability is a better prognostic indicator in neuroblastoma
OBJECTIVE: MYCN oncogene amplification is associated with treatment failure and poor prognosis in neuroblastoma. To date, most detection methods of MYCN focus on DNA copy numbers instead of protein expression, which is the real one performing biological function, for poor antibodies. The current inv...
Autores principales: | Yang, Yi, Zhao, Jie, Zhang, Yingwen, Feng, Tianyue, Yv, Bo, Wang, Jing, Gao, Yijin, Yin, Minzhi, Tang, Jingyan, Li, Yanxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277955/ https://www.ncbi.nlm.nih.gov/pubmed/35820898 http://dx.doi.org/10.1186/s12887-022-03449-1 |
Ejemplares similares
-
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
por: Nagy, Zsuzsanna, et al.
Publicado: (2021) -
FOXR2 Stabilizes MYCN Protein and Identifies Non–MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome
por: Schmitt-Hoffner, Felix, et al.
Publicado: (2021) -
MYCN Function in Neuroblastoma Development
por: Otte, Jörg, et al.
Publicado: (2021) -
MYCN and Metabolic Reprogramming in Neuroblastoma
por: Bansal, Mohit, et al.
Publicado: (2022) -
Metastasis in neuroblastoma: the MYCN question
por: Bhavsar, Swapnil Parashram
Publicado: (2023)